NCT02392104View on ClinicalTrials.gov

Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 27, 2015

Primary Completion Date

June 25, 2017

Study Completion Date

June 25, 2017

Conditions
Anticoagulation
Interventions
DRUG

Warfarin

If the patient's INRs stay within goal range, their interval of INR follow-up will be extended based on a protocol to a maximum of 12 weeks.

All Listed Sponsors
collaborator

University of Wisconsin, Madison

OTHER

lead

William S. Middleton Memorial Veterans Hospital

FED

NCT02392104 - Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service | Biotech Hunter | Biotech Hunter